Press Releases GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.64 ^USD	-4.09%		-14.81%	-30.51%

Mar. 27	Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Mar. 27	GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024	Apr. 25	BU
GlycoMimetics: Q4 Earnings Snapshot	Mar. 27	AQ
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023	Mar. 27	BU
GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024	Mar. 13	BU
GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference	Feb. 26	BU
GlycoMimetics Reports Inducement Grant under NASDAQ Listing Rule 5635(4)	Feb. 13	AQ
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	Feb. 12	BU
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687	Jan. 04	BU
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia	Jan. 03	AQ
GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia	Dec. 10	BU
GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference	Nov. 09	BU
GlycoMimetics: Q3 Earnings Snapshot	Nov. 03	AQ
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023	Nov. 03	BU
GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023	23-10-23	AQ
GlycoMimetics to Report Third Quarter 2023 Financial Results on November 3, 2023	23-10-20	BU
GlycoMimetics Announces First Cohort Dosed in Human Phase 1a Study of GMI-1687	23-09-06	BU
GlycoMimetics to Participate in Upcoming H.C. Wainwright 25th Annual Global Investment Conference	23-09-05	BU
GlycoMimetics Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	23-08-18	AQ
GlycoMimetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	23-08-17	BU
GlycoMimetics: Q2 Earnings Snapshot	23-08-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Press Releases

Filters